Management of Hyperglycemia in Type 2 Diabetes

A Consensus Algorithm for the Initiation and Adjustment of TherapyA Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes

  • PARKIN, CHRISTOPHER G. MS
  • DAVIDSON, JAIME A. MD, FACP, FACE

  • 1CGParkin Communications, Carmel, Indiana

    2Medical City Dallas Hospital, University of Texas Southwestern Medical School, Dallas, Texas.

Address correspondence to Christopher G. Parkin, MS, CGParkin Communications, 11360 Royal Ct., Carmel, IN 46032. E-mail: [email protected]

C.G.P. has received consulting fees from Abbott Diabetes Care, Bayer Diagnostics, Eli Lilly, EMD Pharmaceuticals, Roche Diagnostics, and Sanofi- Aventis Pharmaceuticals.

Diabetes Care 30(1):p 192-193, January 2007.
Copyright © 2007 by the American Diabetes Association, Inc.
View full text|Download PDF